Effects of Matrix Rhythm Therapy in Axial Spondyloarthritis Patients
Launched by IZMIR DEMOCRACY UNIVERSITY · Jul 30, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called matrix rhythm therapy to see how it affects people with axial spondyloarthritis (axSpA), a condition that primarily causes morning stiffness and chronic low back pain. The trial aims to determine if this therapy can improve physical function and overall performance in patients. People aged 18 and older who have been diagnosed with axSpA for at least six months and experience certain levels of discomfort may be eligible to participate.
Participants in the trial can expect to engage in specific therapy sessions and assessments that will help researchers understand the effects of matrix rhythm therapy on their condition. To ensure safety, individuals with certain health issues, such as severe heart problems or uncontrolled diabetes, cannot participate. This trial is currently recruiting, and it welcomes individuals of all genders. If you or a loved one think you might qualify, it could be a valuable opportunity to explore a new approach to managing axSpA symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 years and over
- • Individuals who can understand and respond to assessments
- • Individuals followed with a diagnosis of axial spondyloarthritis for at least 6 months
- • Individuals with a BASDAI score above 4
- Exclusion Criteria:
- • Individuals with unstable angina pectoris, uncompensated heart failure, myocardial infarction in the last month, which may pose a risk during exercise practices
- • Individuals with uncontrolled diabetes, hypertension above 180/110 mmHg and/or severe neuropathy
- • Individuals with diagnosed psychiatric illness
- • Individuals with diagnosed severe cognitive impairment
- • Individuals with severe dyspnea, cyanosis, hemoptysis at rest and/or minimal exertion
- • Individuals with previous spinal injury and/or surgery
- • Individuals with Psoriasis, Irritable Bowel Disease
- • Individuals with pregnancy status/suspicion
- • Patients with total ankylosis on direct radiograph or bamboo cane appearance on thoracolumbar radiograph
About Izmir Democracy University
Izmir Democracy University is a forward-thinking academic institution dedicated to advancing research and innovation in the healthcare sector. As a clinical trial sponsor, the university emphasizes a commitment to ethical standards, scientific rigor, and interdisciplinary collaboration. With a strong focus on improving patient outcomes and contributing to public health, Izmir Democracy University leverages its academic expertise and state-of-the-art facilities to facilitate clinical research that addresses pressing medical challenges. The university actively engages in partnerships with healthcare professionals and organizations to drive meaningful advancements in clinical practice and health policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
Betül Taspinar, Prof.Dr.
Principal Investigator
Izmir Democracy University
Onur Engin, Assist.Prof.
Principal Investigator
Izmir Democracy University
Önay Gerçik, Assist.Prof.
Principal Investigator
Izmir Democracy University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported